Radiofrequency thermal ablation vs. percutaneous ethanol injection for small hepatocellular carcinoma in cirrhosis: Meta-analysis of randomized controlled trials

American Journal of Gastroenterology

Volumn 104, Issue 2, 2009, Pages 514-524

  Orlando, Ambrogio ^a   Leandro, Gioacchino ^b   Olivo, Mirko ^a   Andriulli, Angelo ^c   Cottone, Mario ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b NATIONAL INSTITUTE FOR DIGESTIVE DISEASES   (Italy)

^c CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER PATIENT; CANCER RECURRENCE; CLINICAL TRIAL; HUMAN; INTERMETHOD COMPARISON; INTERVENTIONAL RADIOLOGY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; META ANALYSIS; PERCUTANEOUS ETHANOL INJECTION; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; REVIEW; SURVIVAL RATE; SYSTEMATIC REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME;

CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; ETHANOL; HUMANS; INJECTIONS, INTRALESIONAL; LIVER CIRRHOSIS; LIVER NEOPLASMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SOLVENTS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 59749083101     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2008.80     Document Type: Review

References (31)

1. El-Serang HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340:740-50.
2. Yuen MF, Chen CC, Lauder IJ et al. Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience. Hepatology 2000;31:330-5.
3. Colombo M, Sangiovanni A. The European approach to hepatocellular carcinoma. Hepatogastroenterology 2002;49:12-6.
4. Bruix J, Llovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 2002;35:519-24.
5. Llovet JM, Fuster J, Bruix J. Intention to treat analysis of surgical treatment for early hepatocellular carcinoma: resection vs transplantation. Hepatology 1999;30:1434-40.
6. Sugiura S, Takara K, Ohto M et al. Treatment of small hepatocellular carcinoma by percutaneous injection of alcohol into tumor with real-time ultrasound monitoring. Acta Hepatol Jpn 1983;24:920.
7. Livraghi T, Festi D, Monti F et al. Ultrasound-guided percutaneous ethanol injection of small hepatic and abdominal tumors. Radiology 1986;161:309-12.
8. Bruix J, Dherman M, Llovet JP, et al., for the panel of experts on HCC. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference. J Hepatol 2001;35:421-30.
9. Rossi S, Di Stasi M, Buscarini E et al. Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. Am J Roentgenol 1996;167:759-68.
10. De Baere T, Risse O, Kuoch V et al. Adverse events during radiofrequency treatment of 582 hepatic tumors. Am J Roentgenol 2003;181:695-700.
11. Bruix J, Sherman M, Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 2005;42:1208-36.
12. Livraghi T, Goldberg SN, Lazzaroni S et al. Small hepatocellular carcinoma: treatment with radiofrequency ablation vs ethanol injection. Radiology 1999;210:655-61.
13. Ikeda M, Okada S, Ueno H et al. Radiofrequency ablation and percutaneous ethanol injection in patients with small hepatocallular carcinoma: comparative study. Jpn J Clin Oncol 2001;31:322-6.
14. Lencioni RA, Allgaier HP, Cioni D et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation vs percutaneous ethanol injection. Radiology 2003;228:235-40.
15. Lin SM, Lin CJ, Lin CC et al. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or=4 cm. Gastroenterology 2004;127:1714-23.
16. Shiina S, Teratani T, Obi S et al. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005;129:122-30.
17. Lin SM, Lin CJ, Lin CC et al. Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 2005;54:1151-56. [published erratum appears in Gut 2005; 54(10):1508.]
18. Brunello F, Veltri A, Crucci P et al. Radiofrequency ablation vs ethanol injection for early hepatocellular carcinoma: a randomized controlled trial. Scand J Gastroenterol 2008;43:6, 727-35.
19. Mazzaferro V, Regalia E, Doci R et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693-9.
20. Jadad AR, Moore RA, Carroll D et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1-12.
21. Moher D, Pham B, Jones A et al. Does quality of reports of randomised trials affect estimates of intervention efcacy reported in meta-analyses? Lancet 1998;352:609-13.
22. Juni P, Altman DG, Egger M. Assessing the quality of controlled clinical trials. BMJ 2001;323:42-6.
23. Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Ann Intern Med 2001;135:982-9.
24. Schulz KF, Grimes DA. Generation of allocation sequences in randomised trials: chance not choice. Lancet 2002;359:515-9.
25. Schulz KF, Grimes DA. Allocation concealment in randomised trials: defending against deciphering. Lancet 2002;359:614-8.
26. Schultz KF, Grimes AD. Blinding in randomised trials. Lancet 2002;359:696-700.
27. Klein S, Simes J, Blackburn GL. Total parenteral nutrition and clinical cancer trial. Cancer 1986;58:1378-86.
28. Leandro G. Meta-Analysis in Medical Research. BMJ Books and Blackwell Publishing, Cambridge, UK, 2005.
29. Sasaki A, Kai S, Iwashita Y et al. Microsatellite distribution and indication for locoregional therapy in small hepatocellular carcinoma. Cancer 2005;103:299-306.
30. Cammà C, Di Marco V, Orlando A et al. Unità Interdipartimentale Neoplasie Epatiche (U.I.N.E) Group. Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA): a prospective study. J Hepatol 2005;42:535-40.
31. Horiike N, Iuchi H, Ninomiya T et al. Influencing factors for recurrence of hepatocellular carcinoma treated with radiofrequency ablation. Oncol Rep 2002;9:1059-62.